Johnson & Johnson (NYSE:JNJ) is continuing to develop its diabetes offerings, with its LifeScan business partnering with Qualcomm Life to improve its OneTouch Verio Flex blood glucose meters and launching a next-gen version of its OneTouch Reveal mobile app.

The company will be partnering with the Qualcomm subsidiary to streamline wireless data capture from LifeScan’s OneTouch Verio Flex glood glucose meters using Qualcomm Life’s medicla-grade 2net solution system.

With the integration of the 2net system, physicians will be able to access patients blood glucose data from the OneTouch Verio Flex system through Bluetooth, with the device wirelessly transmitting data to the OneTouch Reveal cloud-based application. Prior to 2net integration, data capture was performed manually.

“Enabling timely access to blood glucose data generates actionable insights for physicians and patients for more informed diabetes care management. The secure, wireless data capture that 2net provides is valuable for clinicians as they seek transformative ways to treat people with diabetes efficiently and effectively across the care continuum,” Qualcomm Life prez Rick Valencia said in a prepared statement.

The companies said they plan to deploy the 2net solution to select offices in Fall this year, with a global expansion planned for 2018.

LifeScan also announced the launch of a new version of its OneTouch Reveal mobile application, with new features which aim to improve how patients integrate blood sugar and activity information into their daily life choices.

New features to the program include a visual timeline as well as a visual logbook, a fingerprint login, an events newsfeed with relevant articles, set reminders, average readings over 14-day to 90-day time periods and a break out of pre and post-meal tagged results, the company said.

“Self-monitoring of blood glucose is still the most accurate, effective and accessible way people with diabetes can track their blood sugars. Now with our new OneTouch Reveal mobile app and digital platform, we can use enhanced connectivity and the new user experience to help patients use that information to make meaningful decisions and take an active role in their diabetes management. It’s this interconnected diabetes management system that changes the way patients see their blood sugar and enables physicians like me to help them find the right track to better diabetes self-management,” LifeScan CMO Dr. Brian Levy said in a press release.

The new version of the OneTouch Reveal app is available for free on Apple devices and Google Android devices in 11 countires, the company said.

“We designed the new interface with engaging social networking apps in mind to appeal to patients new to digital diabetes apps, and to delight current OneTouch Reveal users. Users can quickly see the important events in their blood sugar right up front, like a news feed; and the meter and app pairing are now as simple as consumers have come to expect from popular devices like fitness trackers. For us, it’s all about helping our patients to quickly see and understand their results, so they can apply that knowledge to future actions and move forward,” LifeScan global franchise VP Saleem Ahamed said in a prepared release.

NEXT: Dexcom touts A1C reductions with for MDI patients using CGM